Trade

ZIM Laboratories share price

High risk
  • 58%Low risk
  • 58%Moderate risk
  • 58%Balanced risk
  • 58%High risk
  • 58%Extreme risk
  • 83.08(4.83%)
    April 21, 2026 12:30:02 PM IST
    • NSE
    • BSE
  • Vol : 55.87 K (NSE + BSE)
    Last 20 day avg : 102.27 K

ZIM Laboratories is trading 4.83% upper at Rs 83.08 as compared to its last closing price. ZIM Laboratories has been trading in the price range of 83.08 & 79.71. ZIM Laboratories has given 10.48% in this year & 8.74% in the last 5 days. ZIM Laboratories has TTM P/E ratio 50.07 as compared to the sector P/E of 25.29.The company posted a net profit of 4.40 Crores in its last quarter.Listed peers of ZIM Laboratories include Divi's Laboratories (-0.31%), Sun Pharmaceutical Industries (0.04%), Dr Reddy's Laboratories (-0.91%).The Mutual Fund holding in ZIM Laboratories was at -% in . The MF holding has - from the last quarter. The FII holding in ZIM Laboratories was at 0.02% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Apr 21, 2026, 07:03 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    2.12
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.47
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    1.53
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    55.06
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -1.59
    Indicates undervaluation
Price range
Day Range
Lowest
79.71
Highest
83.08
52 week range
Lowest
59.72
Highest
126.95
ZIM Laboratories Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Neutral
6,261.60-0.311,66,590.4878.6111.520.460.01
Sun Pharmaceutical Industries
Bearish
1,668.650.044,00,355.5936.245.770.920.50
Dr Reddy's Laboratories
Bearish
1,221.00-0.911,02,134.7818.633.140.632.34
Cipla
Moderately Bearish
1,230.900.1699,458.2922.953.870.870.81
Torrent Pharmaceuticals
Bullish
4,161.00-0.651,40,927.4867.3217.10.8317.62
ZIM Laboratories Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-11Quarterly Results
2026-01-21Others
2025-11-12Quarterly Results
2025-08-07Quarterly Results
2025-05-20Audited Results
About the company ZIM Laboratories
  • IndustryBiotechnology & Drugs
  • ISININE518E01015
  • BSE Code541400
  • NSE CodeZIMLAB
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
  • Management Info
  • Anwar DaudExecutive Chairman of the Board, Managing Director
  • Shyam PatroChief Financial Officer
  • Zulfiquar KamalDirector - Finance, Executive Director
  • Piyush NikhadeCompliance Officer, Company Secretary
  • Niraj DhadiwalWhole - Time Director
  • Prakash SapkalWhole - Time Director
ZIM Laboratories Share Price FAQs

ZIM Laboratories is trading at 83.08 as on Tue Apr 21 2026 07:00:02. This is 4.83% upper as compared to its previous closing price of 79.25.

The market capitalization of ZIM Laboratories is 445.89 Cr as on Tue Apr 21 2026 07:00:02.

The 52 wk high for ZIM Laboratories is 126.95 whereas the 52 wk low is 59.72

ZIM Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 50.07
  • Sector P/E: 25.29
  • Dividend Yield: 0.00%
  • D/E ratio: -

ZIM Laboratories reported a net profit of 12.17 Cr in 2025.